About Phialogics

We are a preclinical company developing cell-type-specific immune checkpoint activators to prevent multi-organ failure in autoimmune diseases.

We engineer next generation biologics that rebalance the immune response in acute and chronic inflammation.

Facts about Phialogics
  • Founding: 2021
  • Focus : Manufacturer
  • Industry : Biotechnology, Pharma

Here you will find Phialogics AG